Amgen Inc (NASDAQ:AMGN)

151.60
Delayed Data
As of Jun 29
 -6.42 / -4.06%
Today’s Change
114.93
Today|||52-Week Range
173.60
-4.83%
Year-to-Date

Today’s Trading

Previous close158.02
Today’s open156.63
Day’s range151.43 - 157.96
Volume4,784,789
Average volume (3 months)3,232,727
Market cap$120.1B
Dividend yield2.08%
Data as of 4:14pm ET, 06/29/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+9.89%
Earnings growth (next 5 years)+10.46%
Revenue growth (last year)+7.30%
P/E ratio20.5
Price/Sales6.12
Price/Book4.66

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-12.52-3.06%
GILDGilead Sciences-4.05-3.38%
BAXBaxter International...-1.27-1.77%
BLUEbluebird bio Inc-6.40-3.86%
Data as of 4:14pm ET, 06/29/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)$2.41
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers